Profit Margin (Quarterly)

Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues

Edwards Lifesciences Corporation (EW) had Profit Margin of 13.89% for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$1.74B
Net Income	$241.90M
Cost of Goods Sold	$392.40M
Gross Profit	$1.35B
Operating Expenses	$1.23B
Operating Income	$513.20M
Non-Operating Income/Expense	$6.60M
Pre-Tax Income	$519.80M
Normalized Pre-Tax Income	$559.80M
Income after Taxes	$241.40M
Income from Continuous Operations	$241.40M
Consolidated Net Income/Loss	$241.40M
Normalized Income after Taxes	$302.82M
EBIT	$513.20M
EBITDA	$555.90M
Weighted-Average Shares Outstanding (Basic)	576.40M
Weighted-Average Shares Outstanding (Diluted)	577.60M
Earnings per Share (EPS) (Basic)	$0.42
Earnings per Share (EPS) (Diluted)	$0.42
Balance Sheet Financials
Current Assets	$6.82B
Property, Plant, and Equipment	$1.84B
Long-Term Assets	$7.05B
Total Assets	$13.87B
Current Liabilities	$1.51B
Long-Term Debt	$598.70M
Long-Term Liabilities	$1.63B
Total Liabilities	$3.14B
Common Equity	$10.72B
Tangible Shareholders Equity	$7.39B
Shareholders Equity	$10.72B
Common Shares Outstanding	576.60M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$695.70M
Cash Flow from Investing Activities	$-286.00M
Cash Flow from Financial Activities	$-451.50M
Beginning Cash	$2.94B
End Cash	$2.91B
Increase/Decrease in Cash	$-29.80M
Stock-Based Compensation	$87.60M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.52
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.05
Debt to Equity Ratio	0.06
Gross Margin	77.46%
Operating Margin	29.48%
EBIT Margin	29.48%
EBITDA Margin	--
Pre-Tax Profit Margin	29.86%
Profit Margin	13.89%
Free Cash Flow	$563.90M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	0.35
Receiveable Turnover	1.82
Days Sales in Receivables	49.40
Return on Equity	2.25%
Return on Tangible Equity	3.27%
Return on Assets	1.74%
Return on Investments	2.13%
Book Value Per Share	$18.60
Free Cash Flow per Share	$0.98
Operating Cash Flow per Share	$1.20

Data from Zacks Investment Research, Inc.